当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Zokinvy
申请企业
EIGER BIOPHARMACEUTICALS INC
承诺描述
Complete the ongoing clinical trial EIG-LNF-019 to determine the relative bioavailability of lonafarnib mixed with apple sauce and suspended in orange juice compared with an intact Zokinvy capsule following a single dose administration in healthy subjects.